Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 1.49 B

Quest Diagnostics Incorporated Operating Cash Flow is USD 1.49 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 12.16% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 1.33 B, a 0.00% change year over year.
  • Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.33 B, a -32.80% change year over year.
  • Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.98 B, a -20.37% change year over year.
  • Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 2.49 B, a 104.86% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities